| __timestamp | Grifols, S.A. | Jazz Pharmaceuticals plc |
|---|---|---|
| Wednesday, January 1, 2014 | 1656170000 | 117418000 |
| Thursday, January 1, 2015 | 2003565000 | 102526000 |
| Friday, January 1, 2016 | 2137539000 | 105386000 |
| Sunday, January 1, 2017 | 2166062000 | 110188000 |
| Monday, January 1, 2018 | 2437164000 | 121544000 |
| Tuesday, January 1, 2019 | 2757459000 | 127930000 |
| Wednesday, January 1, 2020 | 3084873000 | 148917000 |
| Friday, January 1, 2021 | 2970522000 | 440760000 |
| Saturday, January 1, 2022 | 3832437000 | 540517000 |
| Sunday, January 1, 2023 | 4269276000 | 435577000 |
Unlocking the unknown
In the competitive landscape of pharmaceuticals, understanding cost dynamics is crucial. Jazz Pharmaceuticals plc and Grifols, S.A. have shown distinct trends in their cost of revenue from 2014 to 2023. Grifols, S.A. has seen a steady increase, with costs rising by approximately 158% over the decade, peaking in 2023. This growth reflects their expanding operations and market reach. In contrast, Jazz Pharmaceuticals plc experienced a more modest increase of around 271%, with a notable spike in 2021, suggesting strategic investments or expansions. These trends highlight the differing strategies and market conditions faced by these companies. As the pharmaceutical industry continues to evolve, monitoring such financial metrics provides valuable insights into company performance and strategic direction.
Comparing Cost of Revenue Efficiency: Eli Lilly and Company vs Jazz Pharmaceuticals plc
Cost of Revenue Trends: Novo Nordisk A/S vs Jazz Pharmaceuticals plc
Analyzing Cost of Revenue: Pfizer Inc. and Jazz Pharmaceuticals plc
Analyzing Cost of Revenue: Sanofi and Jazz Pharmaceuticals plc
Analyzing Cost of Revenue: GSK plc and Grifols, S.A.
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and Jazz Pharmaceuticals plc
Cost Insights: Breaking Down Teva Pharmaceutical Industries Limited and Grifols, S.A.'s Expenses
Comparing Cost of Revenue Efficiency: Jazz Pharmaceuticals plc vs Ionis Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for Jazz Pharmaceuticals plc and CRISPR Therapeutics AG
Analyzing Cost of Revenue: Jazz Pharmaceuticals plc and Supernus Pharmaceuticals, Inc.
Cost of Revenue Comparison: Jazz Pharmaceuticals plc vs Dyne Therapeutics, Inc.
Cost of Revenue Trends: Grifols, S.A. vs BioCryst Pharmaceuticals, Inc.